On 29 February, Valeant Pharmaceuticals International Inc. (NYSE: VRX) admitted that it was under more regulator investigations: “In response to … More
Independent analysis of political, environmental, social, economic and security issues. All views are my own.
On 29 February, Valeant Pharmaceuticals International Inc. (NYSE: VRX) admitted that it was under more regulator investigations: “In response to … More